(0.63%) 5 078.25 points
(0.48%) 38 253 points
(0.74%) 17 568 points
(0.06%) $79.05
(2.17%) $1.974
(-0.42%) $2 301.30
(-1.66%) $26.31
(0.41%) $958.80
(0.21%) $0.935
(0.34%) $11.07
(0.13%) $0.800
(-1.45%) $91.91
Quarter results tomorrow
(bmo 2024-05-03)
Expected move: +/- 2.20%
0.97% £ 624.00
Live Chart Being Loaded With Signals
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies...
Stats | |
---|---|
Объем за сегодня | 65 219.00 |
Средний объем | 60 155.00 |
Рыночная капитализация | 235.30M |
EPS | £0 ( 2024-04-30 ) |
Дата следующего отчета о доходах | ( £0 ) 2024-05-03 |
Last Dividend | £14.20 ( 2023-07-27 ) |
Next Dividend | £0 ( N/A ) |
P/E | 36.71 |
ATR14 | £3.38 (0.54%) |
Объем Корреляция
International Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
International Корреляция - Валюта/Сырье
International Финансовые показатели
Annual | 2023 |
Выручка: | £8.49M |
Валовая прибыль: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2023 |
Выручка: | £8.49M |
Валовая прибыль: | £8.49M (100.00 %) |
EPS: | £0.170 |
FY | 2022 |
Выручка: | £-21.10M |
Валовая прибыль: | £-21.10M (100.00 %) |
EPS: | £-0.550 |
FY | 2021 |
Выручка: | £29.12M |
Валовая прибыль: | £0.00 (0.00 %) |
EPS: | £0.725 |
Financial Reports:
No articles found.
International Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£15.70 (N/A) |
£14.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£14.20 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £1.000 | 1995-11-13 |
Last Dividend | £14.20 | 2023-07-27 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | £191.80 | -- |
Avg. Dividend % Per Year | 2.11% | -- |
Score | 4.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.50 | |
Div. Directional Score | 8.52 | -- |
Year | Amount | Yield |
---|---|---|
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £41.00 | 7.36% |
2019 | £26.40 | 4.63% |
2020 | £26.60 | 4.28% |
2021 | £29.90 | 3.70% |
2022 | £29.70 | 4.04% |
2023 | £14.20 | 1.97% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
THRG.L | Dividend Knight | 2023-08-03 | Semi-Annually | 52 | 1.02% | |
LMP.L | Dividend Knight | 2023-08-31 | Quarterly | 17 | 2.52% | |
CMCL.L | Dividend Knight | 2023-07-13 | Quarterly | 12 | 3.19% | |
RIII.L | Dividend Knight | 2023-08-24 | Semi-Annually | 44 | 1.13% | |
HCFT.L | Dividend Knight | 2023-09-21 | Semi-Annually | 32 | 4.67% | |
ASY.L | Dividend Knight | 2023-05-25 | Semi-Annually | 32 | 2.95% | |
ULVR.L | Dividend King | 2023-08-03 | Quarterly | 33 | 2.11% | |
MINI.L | No Dividend Player | 2023-09-28 | Annually | 9 | 0.05% | |
DATA.L | Dividend King | 2023-09-07 | Semi-Annually | 9 | 7.09% | |
SEQI.L | Dividend Knight | 2023-07-27 | Quarterly | 10 | 3.85% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.651 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0223 | 1.200 | 9.26 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0241 | 1.500 | -0.844 | -1.265 | [0.1 - 1] |
payoutRatioTTM | 1.674 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 19.01 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.213 | -1.500 | 6.45 | -9.67 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.66 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.240 | -1.500 | 9.04 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.629 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.420 | 1.000 | 8.78 | 8.78 | [0.2 - 2] |
assetTurnoverTTM | 0.0343 | 0.800 | -3.10 | -2.48 | [0.5 - 2] |
Total Score | 10.54 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.62 | 1.000 | 6.40 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0241 | 2.50 | -0.542 | -1.265 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.55 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.676 | 2.00 | 9.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.674 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 27.97 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 2.61 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.50 |
International
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа